Ethical, legal, and social implications

Principles of Molecular Medicine

Volumn , Issue , 2006, Pages 61-65

  Van Riper, Marcia ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

Discrimination; ethics; genetic information; genetics; genome; pharmacogenomics

Indexed keywords

EID: 70350751768     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-59259-963-9_9     Document Type: Chapter

References (33)

1. Brower V. Genomics and health care. How genomics medicine is translated into better health care largely depends on how physicians handle this information. EMBO Rep 2004;5:131-133.
2. Chen WY, Garber JE, Higham S, et al. BRCA1/2 genetic testing in the community setting. J Clin Oncol 2002;20:4485-4492.
3. Christian SM, Kieffer SA, Leonard NJ. Medical genetics and patient use of the Internet. Clin Genet 2001;60:232-236.
4. Clayton EW. Ethical, legal, and social implications of genomic medicine. N Engl J Med 2003;349:562-569.
5. Collins FS, Green ED, Guttmacher AE, Guyer MS, US National Human Genome Research Institute. A vision for the future of genomics research. Nature 2003;422:835-847.
6. Collins FS, Guttmacher AE. Genetics moves into the medical mainstream. JAMA 2001;286:2322-2324.
7. Collins FS, McKusick VA. Implications of the Human Genome Project for medical science. JAMA 2001;285:540-544.
8. Forensic Science Service. Fact sheet: The National DNA Database (NDNAD). http://www.forensic.gov.uk/forensic-t/inside/news/docs/ NDNAD.doc. Accessed July 20, 2004.
9. Freedman AN,Wideroff L, Olson L, et al. US physicians' attitudes toward genetic testing for cancer susceptibility. Am J Med Genet 2003;120A: 63-71.
10. GeneWatch UK. Genetic testing and the body shop. http://www.genewatch. org/HumanGen/Tests/BodyShop.htm. Accessed July 20, 2004.
11. Gollust SE, Wilfond BS, Hull SC. Direct-to-consumer sales of genetic services on the internet. Genet Med 2003;5:332-337.
12. Guttmacher AE, Collins FS. Welcome to the genomic era. N Engl J Med 2003;349:996-998.
13. Hampton T. Breast cancer gene chip study under way: can new technology help predict treatment success? JAMA 2004;291:2927-2930.
14. Hartmann LC, Schaid DJ, Woods JE, et al. Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer. N Engl J Med 1999;340:77-84.
15. Hartmann LC, Sellers TA, Schaid DJ, et al. Efficacy of bilateral prophylactic mastectomy in BRCA1 and BRCA2 gene mutation carriers. J Natl Cancer Inst 2001;93:1633-1637.
16. Hayden MR. Predictive testing for Huntington's disease: the calm after the storm. Lancet 2000;356:1944, 1945.
17. Khoury MJ. Genetics and genomics in practice: the continuum from genetic disease to genetic information in health and disease. Genet Med 2003;5:261-268.
18. Meijers-Heijboer H, van Geel B, van Putten WL, et al. Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation. N Engl J Med 2001;345:159-164.
19. Miller PS. Genetic discrimination in the workplace. J Law Med Ethics 1998;26:189-197.
20. O'Neill O. Informed consent and genetic information. Stud Hist Philos Biol Biomed Sci 2001;32:689-704.
21. Peterson EA, Milliron KJ, Lewis KE, Goold SD, Merajver SD. Health insurance and discrimination concerns and BRCA1/2 testing in a clinic population. Cancer Epidemiol Biomarkers Prev 2002;11:79-87.
22. Priori SG, Schwartz PJ, Napolitano C, et al. Risk stratification in the long- QT syndrome. N Engl J Med 2003:348:1866-1874.
23. Ramaswamy S. Translating cancer genomics into clinical oncology. N Engl J Med 2004;350:1814-1816.
24. Robertson JA. The $1000 genome: ethical and legal issues in whole genome sequencing of individuals. Am J Bioeth 2003;3:W35-W42.
25. Roses AD. Pharmacogenetics and the practice of medicine. Nature 2000;405:857-865.
26. Schwartz MD, Lerman C, Brogan B, et al. Impact of BRCA 1/BRCA 2 counseling and testing on newly diagnosed breast cancer patients. J Clin Oncol 2004;22:1823-1829.
27. Sermon K, Van Steirteghem A, Liebaers I. Preimplantation genetic diagnosis. Lancet 2004;363:1633-1641.
28. Singer E, Antonucci T, Van Hoewyk J. Racial and ethnic variations in knowledge and attitudes about genetic testing. Genet test 2004;8:31-43.
29. Thompson HS, Valdimarsdottir HB, Jandorf L, Redd W. Perceived disadvantages and concerns about abuses of genetic testing for cancer risk: differences across African American, Latina, and Caucasian women. Patient Educ Couns 2003;51:217-227.
30. van de Vijver MJ, He YD, van't Veer LJ, et al. A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med 2002;347: 1999-2009.
31. Weitzel JN, McCaffrey SM, Nedelcu R, MacDonald DJ, Blazer KR, Cullinane CA. Effect of genetic risk assessment on surgical decisions at breast cancer diagnosis. Arch Surg 2003;138:1323-1328.
32. Wertz DC. Ethical, social and legal issues in pharmacogenomics. Pharmacogenomics J 2003;3:194-196.
33. Williams-Jones B. Where there's a web, there's a way: commercial genetic testing and the Internet. Community Genet 2003;6:46-57.